Solvonis Therapeutics plc (LON:SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.3600
0.00 (0.00%)
At close: Jul 15, 2025, 4:30 PM BST
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 21.27 million as of July 15, 2025. Its market cap has increased by 12,529.25% in one year.
Market Cap
21.27M
Enterprise Value
20.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 21.27M, a decrease of -7.64%. That is a compound annual growth rate of -2.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 21.27M | 351.95% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rolls-Royce Holdings | 82.63B |
| RELX PLC | 73.43B |
| BAE Systems | 57.13B |
| Experian | 35.23B |
| Ashtead Group | 20.60B |
| International Consolidated Airlines Group | 17.55B |
| Halma | 12.14B |
| Rentokil Initial | 8.65B |